Masimo Inks Deal With Imprivata, Improves Patient Monitoring
Zacks Investment Research | Mar 10, 2020 11:03PM ET
Masimo Corporation (NASDAQ:MASI) recently inked a deal with Imprivata with respect to the integration of Imprivata Medical Device Access into Masimo’s Hospital Automation solutions that feature the Root Patient Monitoring and Connectivity Platform, and Iris Gateway. On the back of this newly launched technology, hospitals are likely to benefit from a more powerful patient monitoring and hospital automation solution created to boost clinical workflows and efficacy in a number of ways.
With this new feature, Masimo will not only add to its SET Pulse Oximeter Technology but also bolster patient monitoring, which in turn will drive growth.
Notably, Masimo’s Root Patient Monitoring and Connectivity Platform helps in making patient care workflows simpler through an easy-to-internet display and multiple network/connectivity options putting together multiple streams of data.
Iris Gateway is part of Masimo’s Hospital Automation solution, which offers third-party device integration and automates transfer of data from medical devices into Electronic Medical Records. This in turn helps in improvement of productivity and lowering the occurrence of transcription errors.
Benefits of Imprivata Medical Device Access
The new technology is part of a comprehensive identity and multifactor authentication platform that enables fast, secure authentication workflows across the healthcare enterprise.
By bringing Imprivata’s authentication technology to Masimo’s customers, the company is likely to improve clients’ experience with monitoring and automation solutions, thereby helping them to stay committed toward enhancing patient outcomes.
Given complexity surrounding Internet of Medical Things (IoMT), many a times healthcare organizations are challenged with the protection of security and integrity of the information stored on and transmitted through medical devices without hampering clinical productivity. Through this partnership, customers are likely to have the capability to implement and enforce the security of sensitive information captured on Root and Iris Platforms, without weighing on clinical workflows.
Patient Monitoring in Focus
Masimo is touted to be the most innovative company in the patient monitoring space. According to Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.